Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 178-180, 2015.
Article in Chinese | WPRIM | ID: wpr-475499

ABSTRACT

Objective To observe the efficacy of urinary kallidinogenase plus batroxobin in the treatment of acute cerebral infarction.Methods 105 patients with acute cerebral infarction were selected and divided into 3 groups:urinary kallidinogenase group (35 cases),combined treatment group (39 cases),batroxobin group (31 cases).The NIHSS score,Barthel Index,MRS score were evaluated before treatment and 10 days after treatment,and the clinical efficacy was compared.Results The NIHSS score significantly decreased after treatment in the three groups (all P < 0.05).The effective rate of combined treatment group was better than that of the single treatment group (urinary kallidinogenase group or batroxobin group) [79.5 % (31/39),71.4 % (25/35),35.4% (11/31) (x2 =15.801,P =0.001)].The Barthel Index and MRS score of combined treatmentgroup were better than those of the batroxobin group (P =0.003),not better than the urinary kallidinogenase group (P =0.766).Conclusion Urinary kallidinogenase plus batroxobin is effective in the treatment of acute cerebral infarction.

2.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 2627-2628, 2011.
Article in Chinese | WPRIM | ID: wpr-421521

ABSTRACT

ObjectiveTo observe the clinic effect of Xueshuantong in subacute cerebral hemorrhage. Methods60 patients with cerebral hemorrhage were randomly divided into treatment group and control group, each grous 30 cases. The control group, only to conventional treatment, the control group addded Xueshuantong 300mg intravenous drip. On the basis treatment in 7 ~21 days of cerebral hemorrhage both groups were checked the NIHSS score and head CT. Before and after the teatment. ResultsAfter 21days,the hematoma volume in the treatment group was ( 3.3 ± 2. 6) ml, the control group was( 7.2 ± 3.7 ) ml, Treatment group was significantly better than the control group (t =4. 102,P < 0.05 ). NIHSS score of treatment group was (4.7 ± 2.8 ) points, the control group was ( 8.6 ± 3.3 )points. Treatment group was significantly lower than the control group( t =5. 329,P < 0.05). ConclusionXueshuantong could promote the absorption of hematoma and the nerve function recovery in subacute cerebral hemorrhage.

SELECTION OF CITATIONS
SEARCH DETAIL